| Prevalence of soft tissue calcifications in patients with SLE and effects of alfacarcidol. | |
| | |
MedLine Citation:
|
PMID: 10483014 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To clarify the prevalence and etiology of ectopic calcification in patients with systemic lupus erythematosus (SLE), especially under the active vitamin D3 administrations and to reveal the risk factors of ectopic calcification. METHODS: Sixty patients with SLE, excluding the patients on dialysis were studied. We examined radiographs of hands, forearms, upper and lower extremities, and pelvises of all patients to evaluate ectopic calcification. RESULTS: The prevalence of ectopic calcification in SLE was 40% (24 out of 60 patients), found in 6.7% (4 patients) in peripheral arteries, 33.3% (20 patients) in periarticular area and 16.7% (10 patients) in other soft tissues. The incidence of lupus nephritis and nephrotic syndrome were significantly higher (respectively: P=0. 0144 and P=0.0348) in the calcification-positive than negative group. Total protein levels (7.04+/-0.6 g/dl) of patients in the calcification-positive group were decreased significantly (P=0.0056) compared with 7.48+/-0.55 g/dl in the negative group. However, other biochemical parameters were not significantly different between the two groups. Sixty-three percent of the SLE patients with ectopic calcification received alfacarcidol, which is significantly (P=0. 0007) higher than the 19% in patients without calcification. CONCLUSION: It is suggested that the alfacarcidol therapy and lupus nephritis could increase the risk of ectopic calcification in SLE patients. |
| | |
Authors:
|
J Okada; M Nomura; M Shirataka; H Kondo |
Related Documents
:
|
3594964 - Epidermal igg deposits in patients with chronic inflammatory connective tissue diseases... 18525434 - Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumato... 19452244 - Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unre... 15163114 - Sinus histocytosis with massive lymphadenopathy (rosai-dorfman disease) in a patient wi... 19789834 - Combined tips with portal-azygous disconnection improved the long term clinical outcome... 1494154 - Dysfunctional grieving. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Lupus Volume: 8 ISSN: 0961-2033 ISO Abbreviation: Lupus Publication Date: 1999 |
Date Detail:
|
Created Date: 1999-11-02 Completed Date: 1999-11-02 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9204265 Medline TA: Lupus Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 456-61 Citation Subset: IM |
Affiliation:
|
Division of Rheumatology, Department of Internal Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Calcinosis / etiology*, immunology Cholecalciferol / adverse effects*, analogs & derivatives, therapeutic use Connective Tissue Diseases / etiology, immunology Female Humans Hydroxycholecalciferols / adverse effects*, therapeutic use Lupus Erythematosus, Systemic / complications*, immunology, therapy Male Middle Aged Prevalence Renal Dialysis / adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Hydroxycholecalciferols; 41294-56-8/1-hydroxycholecalciferol; 67-97-0/Cholecalciferol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides...
Next Document: Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Diseas...